Novo Nordisk announced its oral GLP-1 has been approved by the FDA to reduce risk for major adverse cardiovascular events in ...
In the absence of head-to-head randomized trials, investigators performed a network meta-analysis to compared drugs for post-transplant diabetes.
After clearing Novo Nordisk’s semaglutide treatments Ozempic and Wegovy to reduce the risk of major adverse cardiovascular ...
The drug, called Rybelsus, is the only oral GLP-1 medication available. It was previously approved to treat Type 2 diabetes ...
Everyday Health on MSN
A Guide to Medications for Type 2 Diabetes and Chronic Kidney Disease
Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...
ST. PETERSBURG, Fla. - Count pharmacists among the ranks of health care providers caring for diabetes patients who say they struggle to provide the education and support they need, according to a new ...
Everyday Health on MSN
Should You Be Fibermaxxing for Diabetes?
Fiber can be a strong dietary tool for managing diabetes. But increasing it too much can cause complications with blood sugar and gastrointestinal health.
Verywell Health on MSN
Sugar Alcohols vs. Artificial Sweeteners: Which Is Better for Blood Sugar and Weight Loss?
Sugar alcohols and artificial sweeteners offer similar benefits, but different levels of sweetness, side effects, and nutrition profiles.
Verywell Health on MSN
14 Foods to Eat With Diabetes to Help Prevent Blood Sugar Spikes and Reduce Health Risks
A diabetes diet is a healthy eating plan that helps control your blood sugar. Here are the best foods to eat, no matter what type of diabetes you have.
Presenters at the AAO discussed phase 2 clinical trial results evaluating the safety and efficacy of foselutoclax (UBX1325) compared with aflibercept in diabetic macular edema.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results